At The Forefront of What’s Next
Our goal, which is well underway, is to become a world-class biopharmaceutical company that can independently develop and deliver innovative medicines based on RNAi to patients worldwide. We have a deep pipeline of early to late stage investigational therapies, and 2018 marked the approval of our first medicine—the world’s first RNAi therapeutic. Even though we’ve been around since 2002, we’re just getting started!
We are growing quickly and hiring across North America, Europe, Asia, and Latin America for a wide variety of roles. We’re seeking smart, passionate, “change the world” kind of people who are ready to say, “challenge accepted.” Our 1,000 (and counting!) employees are building a diverse, inclusive, and high-performing global organization that celebrates team achievement and recognizes individual contributions.
We’re at the forefront of what’s next for patients, and perhaps your career also.
Equal Opportunity Employer
Alnylam is an equal opportunity employer and welcomes all job applicants. All qualified applicants will receive consideration for employment without discrimination on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability, or any other factors prohibited by law.
Thank you for taking the time to visit our Careers site. We appreciate your interest in Alnylam.
In the midst of the COVID-19 pandemic, we are evaluating our current job openings to determine the appropriate path forward. While we conduct this analysis, we ask for your patience as response times and communications to applicants may be delayed. Please look for updates on this page soon.
More than ever, we are driven by our mission to translate the Nobel Prize-winning discovery of RNA interference (RNAI) into an innovative, new class of medicines and will continue to seek smart, passionate, change-the-world kind of people who are ready to say, “challenge accepted”.